The CMR presentation will be at 8:30AM Pacific Time on Tuesday 12th January. Biotech Showcase 2016 is hosted at Parc 55 San Francisco, Union Square.
About CMR Surgical
CMR Surgical is a private, British, company developing the next-generation universal robotic system, Versius®, for minimal access (or “keyhole”) surgery.
The vision behind CMR is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics and addressing the six million people who still undergo open surgery each year.
Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1
CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.
For further information, please visit: https://cmrsurgical.com/
*******
Contacts:
CMR Surgical
Martin Frost, Chief Executive Officer
Tel: +44 (0) 1223 755 300
Email: martin.frost@cmedrobotics.com
Consilium Strategic Communications
Mary-Jane Elliott, Ivar Milligan
Tel: +44 20 3709 5700
Email: CMR@consilium-comms.com
____________________________________________